Navigating The Privacy Tightrope For CTIS
The growing scale of EU clinical trials demands robust data privacy through meticulous anonymization to comply with the new Clinical Trials Information System. Biopharmaceutical organizations must adopt best practices for transforming identifiable information, ensuring ethical safeguards while navigating regulatory complexities effectively. This framework highlights the critical need for collaborative responsible data sharing among healthcare stakeholders to protect privacy and accelerate the development of new therapies.
Source: clinicalleader.comPublished on 2023-09-23